Semiconductor microelectronic sensors

Henning, Wolfgang

doi:10.1007/bfb0107940

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Integration of MNs with microelectronic sensors is an emerging domain. The sensor based MNs have the potential to convert non-electrical inputs like temperature or pressure from its surrounding environment to microcomputer readable electrical signals [ 102 ]. Traditionally, blood samples are used/withdrawn from subjects to measure the concentration of the analyte.…”

Section: Different Cancer Treatments Using Mnsmentioning

confidence: 99%

Microneedles Drug Delivery Systems for Treatment of Cancer: A Recent Update

et al. 2020

View full text Add to dashboard Cite

Microneedles (MNs) are tiny needle like structures used in drug delivery through layers of the skin. They are non-invasive and are associated with significantly less or no pain at the site of administration to the skin. MNs are excellent in delivering both small and large molecules to the subjects in need thereof. There exist several strategies for drug delivery using MNs, wherein each strategy has its pros and cons. Research in this domain lead to product development and commercialization for clinical use. Additionally, several MN-based products are undergoing clinical trials to evaluate its safety, efficacy, and tolerability. The present review begins by providing bird’s-eye view about the general characteristics of MNs followed by providing recent updates in the treatment of cancer using MNs. Particularly, we provide an overview of various aspects namely: anti-cancerous MNs that work based on sensor technology, MNs for treatment of breast cancer, skin carcinoma, prostate cancer, and MNs fabricated by additive manufacturing or 3 dimensional printing for treatment of cancer. Further, the review also provides limitations, safety concerns, and latest updates about the clinical trials on MNs for the treatment of cancer. Furthermore, we also provide a regulatory overview from the “United States Food and Drug Administration” about MNs.

show abstract

Section: Different Cancer Treatments Using Mnsmentioning

confidence: 99%